Improper expression and activity of NEK2 has been associated with the development of many cancers, such as lung cancer, hepatocellular carcinoma, multiple myeloma, and pancreatic cancer [17,18,19,20,21]. Here, NEK2 is linked to familial pancreatic carcinoma.